Glipizide Extended-Release Tablets are designed to lower blood glucose by stimulating insulin secretion from the pancreas. It is mainly used for the treatment of mild to moderate type 2 diabetes mellitus that is not satisfied with dietary control alone. Glipizide extended-release tablets mainly through the stimulation of pancreatic secretion of insulin to achieve hypoglycemic effect, its action depends on the function of pancreatic β-cells, is mainly used for pancreatic islet function of type 2 diabetes mellitus patients still exist. It is often used in combination with biguanides or thiazolidinediones and other hypoglycemic drugs to treat type 2 diabetes. During the use of the drug should pay attention to regular monitoring of blood glucose, urine sugar, urine ketones, body urine protein and liver and kidney function, and eye examination, avoid drinking alcohol. Adverse effects of the drug are mainly gastrointestinal symptoms, such as nausea, abdominal pain and so on. Individuals may experience skin irritation. The use of the drug needs to be rationally applied under the guidance of a doctor. If there is any physical discomfort, please consult a doctor promptly.